<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingJeffrey A. Engelman, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Science|2007Cited by 4.5k
Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett, Daniel A. Haber, Elena J. Edelman et al.|Nature|2012Cited by 2.6k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017Cited by 2k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersJeffrey A. Engelman, Kwok‐Kin Wong, Liang Chen et al.|Nature Medicine|2008Cited by 1.3k
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective AnalysisJustin F. Gainor, Mari Mino–Kenudson, Alice T. Shaw et al.|Clinical Cancer Research|2016Cited by 1.2k